Phyllis Harris appointed chief legal and risk officer at ACS

Jacqueline Corrigan-Curay to retire as acting head of CDER at FDA

Jacqueline Corrigan-Curay, the acting director of the Center for Drug Evaluation and Research wrote in an email to colleagues that she will be retiring from the agency in July.

June 27, 2025

Vol.51 No.25

By Claire Marie Porter

In Brief

Nicholas Jaidar named senior administrator for oncology at Johns Hopkins

Nicholas M. Jaidar was named senior administrator for oncology at the Department of Oncology at the Johns Hopkins University School of Medicine and the Johns Hopkins Hospital.

June 27, 2025

Vol.51 No.25

In Brief

Matt Kozlovac named inaugural executive director of Man Up to Cancer

Matt Kozlovac was named the inaugural executive director of Man Up to Cancer, a national nonprofit dedicated to providing social and emotional support for men facing cancer.

June 27, 2025

Vol.51 No.25

Clinical

Young women are now diagnosed with cancer at twice the rate of young men
The face of cancer is changing at a time when research is plagued by existential threats

For more than a year before her stage 4 lung cancer was found, 35-year-old Alisa Secaida, a never-smoker and a physically active Southern Californian, had been experiencing a persistent cough and, increasingly, fatigue.

June 06, 2025

Vol.51 No.22

By Claire Marie Porter

Obituary

Harmon Eyre, former ACS chief medical and scientific officer, dies at 84

Harmon Eyre, MD, died on May 31 in Salt Lake City. He was 84 years old. From 1993 to 2008, he served as the chief medical and scientific officer (CMSO) of the American Cancer Society.

Regulation must keep up with scientific advances

The American Cancer Society’s recent report on the increasing incidence rates of colorectal cancer in young adults once again rang an alarm bell for adults over 45 to get checked, especially if they are having symptoms. But as an oncologist with more than 40 years of experience, I also believe that this should be a clarion call to scientists and researchers, and for regulators at the FDA.

April 25, 2025

Vol.51 No.16

By Richard M. Goldberg

Phyllis Harris appointed chief legal and risk officer at ACS

YOU MAY BE INTERESTED IN

Jacqueline Corrigan-Curay to retire as acting head of CDER at FDA

Nicholas Jaidar named senior administrator for oncology at Johns Hopkins

Matt Kozlovac named inaugural executive director of Man Up to Cancer

Young women are now diagnosed with cancer at twice the rate of young men
The face of cancer is changing at a time when research is plagued by existential threats

Harmon Eyre, former ACS chief medical and scientific officer, dies at 84

Regulation must keep up with scientific advances

Renew today!

Subscriber content

Never miss an issue!

Login

Phyllis Harris appointed chief legal and risk officer at ACS

YOU MAY BE INTERESTED IN

Jacqueline Corrigan-Curay to retire as acting head of CDER at FDA

Nicholas Jaidar named senior administrator for oncology at Johns Hopkins

Matt Kozlovac named inaugural executive director of Man Up to Cancer

Young women are now diagnosed with cancer at twice the rate of young menThe face of cancer is changing at a time when research is plagued by existential threats

Harmon Eyre, former ACS chief medical and scientific officer, dies at 84

Regulation must keep up with scientific advances

Never miss an issue!

Login

Young women are now diagnosed with cancer at twice the rate of young men
The face of cancer is changing at a time when research is plagued by existential threats